Variable | Male N = 391 (58.80%) | Female N = 274 (41.20%) | P value |
---|---|---|---|
Age at diagnosis | 73.68 ± 6.21 | 75.28 ± 7.06 | 0.002 |
Race | Â | Â | 0.083 |
White | 369 (94.37%) | 247 (90.15%) | Â |
Black | 10 (2.56%) | 14 (5.11%) | Â |
Asian or Pacific Islander | 12 (3.07%) | 11 (4.01%) | Â |
American Indian/Alaska Native | 0 | 2 (0.73%) | Â |
Insurance status | Â | Â | 0.838 |
Insured | 137 (35.04%) | 102 (37.23%) | Â |
Uninsured | 2 (0.51%) | 1 (0.36%) | Â |
Unknown | 252 (64.45%) | 171 (62.41%) | Â |
Marital status |  |  |  < 0.001 |
Married | 287 (73.40%) | 111 (40.51%) | Â |
Unmarried | 99 (25.32%) | 157 (57.30) | Â |
Unknown | 5 (1.28%) | 6 (2.19%) | Â |
Site | Â | Â | 0.878 |
Peritoneum | 369 (94.37%) | 261 (95.26%) | Â |
Retroperitoneum | 20 (5.12%) | 12 (4.38%) | Â |
Ovarlapping lesion of retroperitoneum and peritoneum | 2 (0.51%) | 1 (0.36%) | Â |
Histology | Â | Â | 0.531 |
Epithelioid | 116 (29.67%) | 79 (28.83%) | Â |
Biphasic | 11 (2.81%) | 8 (2.92%) | Â |
Sarcomatoid | 8 (2.05%) | 11 (4.01%) | Â |
Unknown | 256 (65.47%) | 176 (64.23%) | Â |
Grade | Â | Â | 0.274 |
Well differentiated | 14 (3.58%) | 19 (6.93%) | Â |
Moderately differentiated | 7 (1.79%) | 4 (1.46%) | Â |
Poorly differentiated | 27 (6.91%) | 21 (7.66%) | Â |
Undifferentiated | 5 (1.28%) | 6 (2.19%) | Â |
Unknown | 338 (86.44%) | 224 (81.76%) | Â |
Stage | Â | Â | 0.190 |
Localized | 32 (8.18%) | 36 (13.14%) | Â |
Regional | 58 (14.83%) | 37 (13.50%) | Â |
Distant | 251 (64.19%) | 163 (59.49%) | Â |
Unknown | 50 (12.79) | 38 (19.87%) | Â |
Surgery |  |  |  < 0.001 |
Cancer-directed surgery done | 100 (25.58%) | 122 (44.53%) | Â |
No cancer-directed surgery | 284 (72.63%) | 146 (53.28%) | Â |
Radiotherapy | Â | Â | 0.605 |
Yes | 10 (2.56%) | 5 (1.82%) | Â |
No/unknown | 381 (97.44%) | 269 (98.18%) | Â |
Chemotherapy | Â | Â | 0.342 |
Yes | 178 (45.78%) | 115 (42.97%) | Â |
No/unknown | 212 (54.22%) | 159 (58.03%) | Â |